FDA OKs Romosozumab for Postmenopausal Osteoporosis
Romosozumab should be reserved for women at high risk for fracture who fail other therapies and should be avoided in women with a history of heart attack or stroke. FDA Approvals …read more
ACP: Breast Cancer Screening Every 2 Years
Women with no breast cancer symptoms should undergo mammography screening every other year, according to a guidance statement from the American College of Physicians. Medscape Medical News …read more
Could this protein explain why migraine is more common in women?
An animal study shows that certain nervous system responses to a protein that scientists have long known to play a role in migraine occur only in females. …read more